Comparison of Figure-Of-Eight Suture Perclose ProGlide Suture-Mediated Closure
1 other identifier
interventional
50
1 country
1
Brief Summary
The study proposes to compare specialized closure devices to achieve hemostasis with the Figure-of-eight suture technique.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 6, 2020
CompletedFirst Submitted
Initial submission to the registry
March 31, 2021
CompletedFirst Posted
Study publicly available on registry
April 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 13, 2022
CompletedJanuary 11, 2023
January 1, 2023
2.4 years
March 31, 2021
January 9, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Hemostasis Time
To assess if an additional device use to achieve hemostasis can be avoided after a large bore venous access
Immediate
Procedure Time
Immediate
Access Site Complication
1 month
Study Arms (2)
Figure-of-eight
ACTIVE COMPARATORUsing the figure-of-eight closure technique when closing access for structural heart therapies.
Perclose Device
ACTIVE COMPARATORUsing the Perclose device when closing access for structural heart therapies.
Interventions
Using the figure-of-eight closure technique when closing access for structural heart therapies.
Using the Perclose device when closing access for structural heart therapies.
Eligibility Criteria
You may qualify if:
- All patients who successfully undergo venous large bore access sheath placement for structural heart procedures.
You may not qualify if:
- Patients who do not consent
- Minors or those unable to consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Delray Medical Centerlead
- Florida Atlantic Universitycollaborator
Study Sites (1)
Delray Medical Center
Delray Beach, Florida, 33484, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Houman Khalili, MD
Delray Medical Center
- PRINCIPAL INVESTIGATOR
Brijeshwar Maini
Delray Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 31, 2021
First Posted
April 5, 2021
Study Start
August 6, 2020
Primary Completion
December 13, 2022
Study Completion
December 13, 2022
Last Updated
January 11, 2023
Record last verified: 2023-01